Fluclotizolam | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 332.8 g/mol [1] |
Predicted LogP | 2.2 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C15H10ClFN4S [1] |
IUPAC name | 4-chloro-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene [1] |
SMILES | CC1=NN=C2N1C3=C(C=C(S3)Cl)C(=NC2)C4=CC=CC=C4F [1] |
InChI | InChI=1S/C15H10ClFN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3 [1] |
InChIKey | ZDYRCUZZLRLMHG-UHFFFAOYSA-N [1] |
Fluclotizolam
Fluclotizolam (also known as 2-Chloro-4-(2-fluorophenyl)-9-methyl-6H-thieno(3,2-F)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 6H-Thieno(3,2-F)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 2-chloro-4-(2-fluorophenyl)-9-methyl-, 2-chloro-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 4-Chloro-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene, ECA12315, HY-135496 or 2-chloro-4-(o-fluorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine) is a
Chemistry
Stereochemistry []
Fluclotizolam is a achiral mixture
Experience reports []
There are currently 1 experience reports involving fluclotizolam on OpenErowid:
Legal status
- Canada: Fluclotizolam is a Schedule IV substance.
- Germany: Fluclotizolam is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Fluclotizolam is a PSA substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 21317700, Fluclotizolam. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/21317700
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fluclotizolam. UNII: 4Z9Y7GEG8Z. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4Z9Y7GEG8Z